In this context, a end-point titration of the vCJD/BSE isolates used in the different transgenic PrP mouse lines (tga20, tgBov, tg338 and tgShXI) has been initiated. The gene discussed is PRNP; the disease is variant Creutzfeldt-Jakob disease.